{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:17:54Z","timestamp":1791404274060,"version":"4.3.3"},"reference-count":23,"publisher":"Centers for Disease Control MMWR Office","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6831e1","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T10:51:30Z","timestamp":1565088690000},"page":"679-686","source":"Crossref","is-referenced-by-count":165,"title":["<i>Vital Signs:<\/i>\n                    Pharmacy-Based Naloxone Dispensing \u2014 United States, 2012\u20132018"],"prefix":"10.15585","volume":"68","author":[{"suffix":"Jr.","given":"Gery P.","family":"Guy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara M.","family":"Haegerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"Losby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017.","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R2","unstructured":"CDC. 2018 Annual surveillance report of drug-related risks and outcomes\u2014United States. Surveillance special report. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2018-cdc-drug-surveillance-report.pdf"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug overdose deaths involving cocaine and psychostimulants with abuse potential\u2014United States, 2003\u20132017.","volume":"68","author":"Kariisa","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R5","unstructured":"US Department of Health and Human Services. Strategy to combat opioid abuse, misuse, and overdose. Washington, DC: US Department of Health and Human Services; 2018. https:\/\/www.hhs.gov\/opioids\/sites\/default\/files\/2018-09\/opioid-fivepoint-strategy-20180917-508compliant.pdf"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R6","unstructured":"Prescription Drug Abuse Policy System. Naloxone overdose prevention laws. Philadelphia, PA: Prescription Drug Abuse Policy System; 2017. http:\/\/pdaps.org\/datasets\/laws-regulating-administration-of-naloxone-1501695139"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.drugalcdep.2018.04.020","article-title":"State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies.","volume":"189","author":"Xu","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R8","doi-asserted-by":"publisher","first-page":"e196215","DOI":"10.1001\/jamanetworkopen.2019.6215","article-title":"Association of naloxone copresciption laws with naloxone prescription dispensing in the United States.","volume":"2","author":"Sohn","year":"2019","journal-title":"JAMA Netw Open"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015.","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R10","unstructured":"CDC, National Center for Health Statistics. NCHS urban-rural classification scheme for counties. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2019. https:\/\/www.cdc.gov\/nchs\/data_access\/urban_rural.htm"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline.","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/jamainternmed.2019.0272","article-title":"Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose.","volume":"179","author":"Abouk","year":"2019","journal-title":"JAMA Intern Med"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R13","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.2105\/AJPH.2014.302520","article-title":"Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities.","volume":"105","author":"Faul","year":"2015","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","article-title":"Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013.","volume":"64","author":"Des Jarlais","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R15","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s11606-015-3394-3","article-title":"Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff.","volume":"30","author":"Binswanger","year":"2015","journal-title":"J Gen Intern Med"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R16","first-page":"122","article-title":"Academic detailing pilot for naloxone prescribing among primary care providers in San Francisco.","volume":"49","author":"Behar","year":"2017","journal-title":"Fam Med"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R17","doi-asserted-by":"crossref","unstructured":"Furlan AD, Zhao J, Voth J,  Evaluation of an innovative tele-education intervention in chronic pain management for primary care clinicians practicing in underserved areas. J Telemed Telecare 2018;24:1357633X18782090. 10.1177\/1357633X18782090","DOI":"10.1177\/1357633X18782090"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R18","doi-asserted-by":"crossref","unstructured":"Marino R, Landau A, Lynch M, Callaway C, Suffoletto B. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose? Addiction 2019. Epub April 23, 2002. 10.1111\/add.14635","DOI":"10.1111\/add.14635"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R19","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1056\/NEJMp1609578","article-title":"The rising price of naloxone\u2014risks to efforts to stem overdose deaths.","volume":"375","author":"Gupta","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.2019.7988","article-title":"Naloxone co-prescribing to patients receiving 2 prescription opioids in the Medicare Part D 3 program, United States, 2016\u20132017","volume":"322","author":"Jones","year":"2019","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R21","unstructured":"Centers for Medicare and Medicaid Services. 2020 Medicare advantage and part D rate announcement and final call letter fact sheet. Baltimore, MD: US Department of Health and Human Services, Centers for Medicare and Medicaid Services; 2019. https:\/\/www.cms.gov\/newsroom\/fact-sheets\/2020-medicare-advantage-and-part-d-rate-announcement-and-final-call-letter-fact-sheet"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R22","unstructured":"US Department of Health and Human Services. U.S. Surgeon General\u2019s advisory on naloxone and opioid overdose. Washington, DC: US Department of Health and Human Services; 2018. https:\/\/www.hhs.gov\/surgeongeneral\/priorities\/opioids-and-addiction\/naloxone-advisory\/index.html"},{"key":"key-10.15585\/mmwr.mm6831e1-201908081036-R23","unstructured":"US Department of Health and Human Services. Naloxone: the opioid reversal drug that saves lives. Washington, DC: US Department of Health and Human Services; 2018. https:\/\/www.hhs.gov\/opioids\/sites\/default\/files\/2018-12\/naloxone-coprescribing-guidance.pdf"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T10:37:46Z","timestamp":1565260666000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/68\/wr\/mm6831e1.htm?s_cid=mm6831e1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":23,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2019,8,9]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6831e1","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8,9]]},"published":{"date-parts":[[2019,8,9]]}}}